Opinions
David Baskin
Bard C R Inc.
BCR-N
PAST TOP PICK
Apr 12, 2016
Stock price when the opinion was issued
You might be interested:
This hit his screen. There is no real volume, however. Single use medical products. 80-85% of revenues are high margin and annuity like. Ripe for the picking by a JNJ or Abbot Labs. There are not a lot of opportunities for them to grow. Buying back a ton of stock, but not raising dividends.
Basically manufactures disposable health supplies that are used, thrown away, and then replenished. Due to the US Affordable Care Act, there are more and more people that are covered and are having operations. It has a bit of a moat in that it is hard to compete with. Also, came out with a balloon that is used in angioplasty and is covered with drugs. Dividend yield of 0.53%.
This makes disposable health care products. It is expanding its empire by rapidly growing in emerging markets. Not facing the same kind of pressures from US politicians as other health care stocks. They have come up with a winning product, a drug coated balloon. This is not a cheap stock, but it is one that generates an ample amount of free cash flow, and one that could easily be swallowed by a company like Medtronic (MDT-N) or Johnson & Johnson (JNJ-N). Dividend yield of 0.47%.
(A Top Pick May 12/15. Up 23.03%.) Not a lot of people know about this company. It is a provider of disposable medical supplies. Have something like 25,000 different items that they sell to hospitals. Because of aging population, demand for healthcare is rising all the time.